Stony Brook University’s Boros Lab has begun a new stage in their research of radioactive scandium isotopes in medical chemistry with the goal of creating a new treatment for prostate cancer.
The theme of this year’s meeting was “Bringing Cancer Discoveries to Patients,” bridging the gap between scientists at the lab bench and patients in the clinic.
